Lifecore Biomedical, Inc. De (LFCR) Cash from Operations (2010 - 2025)

Lifecore Biomedical's Cash from Operations history runs 16 years deep, the most recent figure standing at 5347000.0 for Q2 2025.

• In Q2 2025, Cash from Operations fell 38.65% year-over-year to 5347000.0; the TTM figure through May 2025 stood at 207000.0 (down 180.54% YoY), while the FY2025 annual figure was 206000.0, down 180.16% from the prior year.
• Cash from Operations was 5347000.0 for Q2 2025 at Lifecore Biomedical, up from 1199000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 8716000.0 in Q2 2024 to a low of 17310000.0 in Q1 2022.
• Historically, Cash from Operations has averaged 2354333.33 across 5 years, with a median of 1635000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Cash from Operations tumbled 656.49% in 2023, then jumped 485.32% in 2024.
• A 5-year view of Cash from Operations shows it stood at 4810000.0 in 2021, then soared by 51.08% to 2353000.0 in 2022, then soared by 154.74% to 1288000.0 in 2023, then sank by 576.71% to 6140000.0 in 2024, then surged by 187.08% to 5347000.0 in 2025.
• The last three Cash from Operations figures came in at 5347000.0 (Q2 2025), 1199000.0 (Q1 2025), and 6140000.0 (Q4 2024), per Business Quant data.